Evidence map›Paper›PMID 32024435›Full record

ArticleGut microbes2020

Strain-level analysis of gut-resident pro-inflammatory viridans group Streptococci suppressed by long-term cotrimoxazole prophylaxis among HIV-positive children in Zimbabwe.

Ethan K Gough, Claire D Bourke, Chipo Berejena, Annie Shonhai, Mutsa Bwakura-Dangarembizi, Andrew J Prendergast, Amee R Manges

Open access · goldAbstract read
In one paragraph

Article in Gut microbes, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Ethan K GoughDepartment of International Health, Division of Human Nutrition, Johns Hopkins Bloomberg School of Public Health , Baltimore, MD, USA.ORCID 0000-0001-5265-7731
Claire D BourkeBlizard Institute, Queen Mary University of London , London, UK.ORCID 0000-0002-7244-0895
Chipo BerejenaCollege of Health Sciences, University of Zimbabwe , Harare, Zimbabwe.
Annie ShonhaiCollege of Health Sciences, University of Zimbabwe , Harare, Zimbabwe.
Mutsa Bwakura-DangarembiziCollege of Health Sciences, University of Zimbabwe , Harare, Zimbabwe.
Andrew J PrendergastBlizard Institute, Queen Mary University of London , London, UK.
Amee R MangesSchool of Population and Public Health, University of British Columbia , Vancouver, Canada.
University of Zimbabwe · ZWQueen Mary University of London · GBJohns Hopkins University · USUniversity of British Columbia · CA

Funding

CIHRMedical Research Council G0300400Medical Research Council G1001190Medical Research Council MC_EX_G0300400Medical Research Council MC_U122886353Medical Research Council MC_UU_12023/17Medical Research Council MC_UU_12023/26Wellcome TrustWellcome Trust 093768/Z/10/ZWellcome Trust 108065/Z/15/ZWellcome Trust 206225/Z/17/Z
6 · The paper itself

Abstract

Antimicrobials have become a mainstay of healthcare in the past century due to their activity against pathogens. More recently, it has become clear that they can also affect health via their impact on the microbiota and inflammation. This may explain some of their clinical benefits despite global increases in antimicrobial resistance (AMR) and reduced antimicrobial effectiveness. We showed in a randomized controlled trial of stopping versus continuing cotrimoxazole prophylaxis among HIV-positive Zimbabwean children taking antiretroviral therapy (ART), that continuation of cotrimoxazole persistently suppressed gut-resident viridans group streptococcal species (VGS) that were associated with intestinal inflammation. In this addendum, we provide a broader overview of how antibiotics can shape the microbiota and use high read-depth whole metagenome sequencing data from our published study to investigate whether (i) the impact of cotrimoxazole on gut VGS and (ii) VGS associated inflammation, is attributable to strain-level variability. We focus on

Indexed as

Antibiotic ProphylaxisAnti-Bacterial AgentsAnti-HIV AgentsChildFecesGastrointestinal MicrobiomeHIV InfectionsHumansInflammationIntestinesSpecies SpecificityStreptococcus salivariusTrimethoprim, Sulfamethoxazole Drug CombinationViridans StreptococciZimbabweAnti-Bacterial AgentsAnti-HIV AgentsTrimethoprim, Sulfamethoxazole Drug Combinationantimicrobial resistancecotrimoxazolegut healthHIVimmune modulationinflammationmicrobiotaseptraseptrin

Identifiers

PMID32024435
PMCPMC7524282
OpenAlexW3005506267

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.